South Korea Gets Biopharma Boost with CMO Samsung BioLogics $740 Million Investment

SUGAR LAND, TEXAS--April 21, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Samsung BioLogics (Incheon, South Korea) is busy raising South Korea's profile within the global biopharma industry. 100% of its products in the country are exported.

Within this article: Details on the progress of Samsung BioLogics' projects.